HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • Responding to and Recovering from the COVID-19 Pandemic
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Health Research Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation

What's Being Said

  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › What's Being Said
  4. › AstraZeneca: Investing in Canadian Scientific Excellence
AstraZeneca: Investing in Canadian Scientific Excellence

AstraZeneca: Investing in Canadian Scientific Excellence

September 25, 2019September 25, 2019

With an ambition to push the boundaries of science and advance understanding of the underlying biology of disease, AstraZeneca has built one of the strongest small molecule and biologics pipelines in the biopharmaceutical industry. At the heart of our work is a deep commitment to addressing unmet medical need and delivering life-changing medicines to patients.

AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Poised to launch more than 20 new medicines and indications within the next few years, AstraZeneca is focused on driving innovative science in three important areas of healthcare: Cardiovascular, Renal and Metabolic disease; Oncology; and Respiratory, Inflammation and Autoimmunity. Precision medicine and genomics is fundamental to the way AstraZeneca scientists work across all three areas, and in collaboration with world-leading academic partners in Canada and globally.

Globally, the company operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. In Canada, we employ more than 850 employees across the country and our AstraZeneca Canada headquarters are located in Mississauga, Ontario.

In addition to a rapidly expanding clinical footprint in Canada, AstraZeneca is engaged in a number of novel research partnerships with world-class researchers across the country. Tapping into the strong Canadian health sciences infrastructure, AstraZeneca Canada invested more than $102 million in Canadian R&D in 2018 alone.  AstraZeneca Canada was also recently designated a key Global Clinical Trial Delivery site for AstraZeneca globally – leading the development for more than 60 global clinical trials and playing an integral role in the development of many of AstraZeneca’s pipeline compounds in oncology, immuno-oncology and respiratory disease.

For more information about AstraZeneca Canada, please visit the company’s website at www.astrazeneca.ca.

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease; Oncology; and Respiratory, Inflammation and Autoimmunity. For more information: www.astrazeneca.ca.

Taking a next-generation approach to health careThe most powerful tool in advancing health care is evidence
  • AstraZeneca
  • Innovative Medicines Canada - Médicaments novateurs Canada
  • Roche

Contact Us

Tweets

  • 2 years ago RT @hri_portal: New on the Guest Blog: Changing the course of #arthritis Pediatric arthritis affects over 25K children and youth, but @Ar…
  • 2 years ago RT @KBI_UHN: Learn all about the latest research in #concussion & traumatic #braininjury in Episode 7 of @KBI_UHN's #YourComplexBrain #podc…
  • 2 years ago RT @McMasterPMM: Read more about Dr. Fiona Smaill's work on the aerosol vaccine here: https://t.co/dyN23bKWNe
  • 2 years ago A huge thank you to our Members, Parliamentarians and guests who joined us for our 18th Annual General Meeting! Ch… https://t.co/KaVxmHlatq

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.